- Lobbying
- Lobbying by Bausch Health Companies, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Charles Brain | Asst. to the President, Dp.Chief Staff W&M Cmte |
A.J. Wojciak | Senior Legislative Asst., Cong. Earl Pomeroy |
Tom Nagle | Chief of Staff, U.S. Senator Tom Udall; Chief of Staff, U.S. Representative Tom Udall; Associate Staff, U.S. House Committee on Appropriations Chief of Staff, U.S. Senator Tom Udall; Chief of Staff, U.S. Representative Tom Udall; Associate Staff, U.S. House Committee on Appropriations |
Patrick O'Neill | n/a |
Nancy O'Neall | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Proposals impacting the prescription drug industry, including issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally. Issues relating to biologics and biosimilars in Medicare and generally..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate